PTO Strikes Down Ariad’s Patent
Though the PTO’s decision is not final—Ariad still has a chance to reply—it does provide Eli Lilly with a bargaining chip in future negotiations and with powerful evidence in future trials.
In the re-examination, the PTO struck down most of Ariad’s claims for obviousness. When something is old, it does not become patentable just because the scientific...
To view the full article, register now.